Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells202
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity169
Exploiting antifungal immunity in the clinical context87
Editorial Board72
Differential immune responses behind different celiac disease manifestations67
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity65
Cellular stress and macrophage activation65
Editorial Board65
Aging of lymphoid stromal architecture impacts immune responses57
Microbial metabolites and immunotherapy: Basic rationale and clinical indications55
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Resolving inflammatory links between myocardial infarction and vascular dementia52
Pyroptosis modulation by bacterial effector proteins49
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges48
Local and Cell-intrinsic complement: The new player in cancer progression48
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity47
Immunity to pathogenic fungi in the eye46
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?41
The noncanonical inflammasome-induced pyroptosis and septic shock41
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease39
Pyroptosis: A road to next-generation cancer immunotherapy38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity37
Pyroptosis and the cellular consequences of gasdermin pores36
Interplay between the complement system and other immune pathways in the tumor microenvironment34
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment33
Western diet influences on microbiome and carcinogenesis33
Specialized pro-resolving mediators as modulators of immune responses32
Autoimmune diabetes and targets for immunomodulation29
Neuroimmune interactions between itch neurons and skin microbes29
Immunity to fungi: Editorial overview28
Cellular and molecular diversity in spondyloarthritis28
The evolving biology of cross-presentation28
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets28
The paradox of aging: Aging-related shifts in T cell function and metabolism27
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Thymus aging and immune reconstitution, progresses and challenges26
TREM2: A new player in the tumor microenvironment26
Sialic acid and Siglec receptors in tumor immunity and immunotherapy24
Antigen discovery for the development of cancer immunotherapy24
Recent developments in C3-targeted complement therapeutics23
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs22
T cell control of SARS-CoV-2: When, which, and where?22
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination22
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases22
Introduction to the Special Issue: Nutrition, microbiota and immunity21
Targeting the tissue-complosome for curbing inflammatory disease21
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic21
T cell fate decisions during memory cell generation with aging20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
Editorial Board19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
The glycoimmune landscape in health and disease19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis18
Proteostasis in T cell aging18
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy18
0.10462689399719